Physician profile
Harry A Lebowitz
NPI 1922051127
$1,568.53
in general payments reported to CMS, 2019-2025
19 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.81 · 2021: $124 · 2022: $482 · 2023: $363 · 2024: $178 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $436.06 | 2021-2024 | Tecnis Iol, Catalys System, Tecnis Iol |
| Genentech USA, INC. | $195.25 | 2019-2025 | Vabysmo |
| Biotissue Holdings INC. | $170.58 | 2019-2025 | |
| Alcon Vision LLC | $170.30 | 2019-2025 | Rocklatan, Clareon, Dailies |
| Apellis Pharmaceuticals, INC. | $135.37 | 2023-2025 | Syfovre |
| Coherus Oncology, INC. | $66.88 | 2023 | |
| Abbvie INC. | $61.97 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $55.47 | 2022-2023 | Infuse, Biotrue One Day |
| Harrow Eye, LLC | $44.60 | 2025 | |
| Allergan, INC. | $35.35 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $30.64 | 2023 | Acthar |
| Rxsight INC | $29.15 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Astellas Pharma US INC | $25.60 | 2025 | Izervay |
| Sun Pharmaceutical Industries INC. | $21.63 | 2019 | |
| Dompe US, INC. | $21.40 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $20.35 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.17 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.39 | 2023 | Eylea Hd |
| Lkc Technologies, INC. | $14.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Lebowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.